UCB's Zogenix Bet Pays Out Quickly With Fresh Fintepla Approval

Second Indication For Rare Epilepsy Potential Blockbuster

 
• By Kevin Grogan
  
Van Zyl, Charl
Charl van Zyl • Source: UCB
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip